Research ArticleLaboratory Studies
Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent
Shrikant V. Deshpande, Sally J. DeNardo, David L. Kukis, Min K. Moi, Michael J. McCall, Gerald L. DeNardo and Claude F. Meares
Journal of Nuclear Medicine April 1990, 31 (4) 473-479;
Shrikant V. Deshpande
Sally J. DeNardo
David L. Kukis
Min K. Moi
Michael J. McCall
Gerald L. DeNardo


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Yttrium-90-Labeled Monoclonal Antibody for Therapy: Labeling by a New Macrocyclic Bifunctional Chelating Agent
Shrikant V. Deshpande, Sally J. DeNardo, David L. Kukis, Min K. Moi, Michael J. McCall, Gerald L. DeNardo, Claude F. Meares
Journal of Nuclear Medicine Apr 1990, 31 (4) 473-479;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Planning Time for Peripheral Blood Stem Cell Infusion After High-Dose Targeted Radionuclide Therapy Using Dosimetry
- Preclinical Evaluation of Cathepsin-degradable Peptide Linkers for Radioimmunoconjugates
- A Novel DOTA-{alpha}-Melanocyte-Stimulating Hormone Analog for Metastatic Melanoma Diagnosis
- Metabolite Production in Patients with Lymphoma After Radiometal-Labeled Antibody Administration
- Hematologic Malignancies
- Site-specific Conjugation on Serine -> Cysteine Variant Monoclonal Antibodies
- Site-specific Conjugation on Serine -> Cysteine Variant Monoclonal Antibodies